Why the study?
Do leadless transcatheter pacemakers reduce device-related complications compared to transvenous pacemakers in patients requiring pacing?
Do leadless transcatheter pacemakers reduce device-related complications compared to transvenous pacemakers in patients requiring pacing?
Leadless pacemakers are associated with a significantly lower risk of late device-related complications compared to traditional transvenous pacemakers, with similar early complication rates.
L-PM was associated with fewer late complications than T-PM; leaves open whether randomized trials will confirm benefit and shift device selection.
In this analysis, the risk of device-related complications associated with L-PM implantation tended to be lower than that of T-PM. Specifically, the risk of early complications was similar in two types of PMs, while the risk of late complications was significantly lower for L-PM than T-PM.
No takes yet. Share an insight, caveat, or question.
Palmisano et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: